Navigation Links
Advanced BioHealing and Regenesis Biomedical Form Co-Promotion Alliance for Dermagraft(R)
Date:5/7/2008

Agreement expands Dermagraft presence within government channels

WEST PORT, Conn., and SCOTTSDALE, Ariz., May 7 /PRNewswire/ -- Advanced BioHealing, Inc. (ABH) and Regenesis Biomedical, Inc. announced today an agreement focused on the promotion of Dermagraft(R) within the United States (US) government healthcare system. Under terms of the agreement Regenesis will provide its specialized sales force to market ABH's product Dermagraft within the Veteran's Administration (VA), Department of Defense (DOD), and TriCare healthcare payer systems.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080422/LATU008)

"Since launching Dermagraft in 2007, we have seen the need for a focused commercial presence within government healthcare systems," said Kevin Rakin, Chairman and CEO of Advanced BioHealing. "The management team at Regenesis has developed a corporate competency in promoting and distributing advanced wound care technology within these systems. We believe this co-promotion is the most effective way to maximize reach and penetration of Dermagraft in this specialized market."

Dermagraft is a bioengineered tissue product approved by the Food and Drug Administration (FDA) for the treatment of diabetic foot ulcers (DFUs). DFUs, a complication of diabetes, affect more than 400,000 people every year in the US. If not treated properly, DFUs can result in serious infection, sometimes resulting in the need for partial or full limb amputation. There are over 100,000 amputations performed annually in the US with more than 80% owing their origin to uncontrolled infection.

"There are many wound care companies that would enjoy the opportunity to promote a product like Dermagraft," says Virginia Rybski, Acting President of Regenesis Biomedical. "ABH has done a tremendous job in promoting the product in the traditional out-patient environment. We are pleased to have
'/>"/>

SOURCE Regenesis Biomedical, Inc.; Advanced BioHealing, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Boston Scientific Announces European Approval and Market Launch of New Family of Advanced Pacemakers
2. Advanced Life Sciences Announces First Quarter 2008 Financial Results
3. Advanced Life Sciences to Host 2008 First Quarter Financial Results Conference Call and Webcast
4. Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness Patients
5. Avastin Used in Combination with Drugs from Bristol-Myers Squibb Has Advantages in Survival Rates Over the Current Sales-Leading Therapy for Advanced Ovarian Cancer
6. Advanced Life Sciences Regains Compliance With Nasdaq Listing Requirements
7. Advanced Life Sciences Announces Plan to Submit NDA for Cethromycin
8. Encision Launches Next Generation of EnTouch(R) Handles for Advanced Laparoscopic Procedures
9. Advanced Life Sciences Receives Nasdaq Notification
10. Advanced Life Sciences Announces Fourth Quarter and Full Year 2007 Financial Results
11. Peregrine Pharmaceuticals Doses First Patient in Phase II Clinical Trial of Bavituximab in Patients With Advanced Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... , July 14, 2014 Cloud ... drug design and development, announced today the expansion ... company has been granted supercomputing time at Argonne ... targets.  Through a discretionary allocation ... Computing Facility (ALCF), researchers at Cloud Pharmaceuticals will ...
(Date:7/14/2014)... July 14, 2014 Throughout this ... across the clinical trials space, representing 38 countries ... series entitled “Optimizing Patient Participation in Clinical Trials. ... off with internationally renowned R&D expert, Ken Getz, ... on Reinventing Drug Development through Patient Centricity. , ...
(Date:7/14/2014)... CAMBRIDGE, Mass. , July 14, 2014 ... in the development of new therapies to treat neuropsychiatric ... Ahlholm has been appointed vice president of finance ... Mr. Ahlholm is a senior executive with more ... functions at technology and life science companies. His background ...
(Date:7/14/2014)... (PRWEB) July 14, 2014 ... registry platform, announced that three PatientCrossroads-based patient ... the Phelan-McDermid Syndrome International Registry; and the ... been awarded contracts by the Patient-Centered Outcomes ... creation of a new health data network ...
Breaking Biology Technology:Cloud Pharmaceuticals Granted 1M Hours of Supercomputer Time to Target Orphan Diseases Including Malaria 2Optimizing Patient Participation in Clinical Trials: Attract. Engage. Retain. – eCongress eBox Archives Now Available 2Optimizing Patient Participation in Clinical Trials: Attract. Engage. Retain. – eCongress eBox Archives Now Available 3Optimizing Patient Participation in Clinical Trials: Attract. Engage. Retain. – eCongress eBox Archives Now Available 4Optimizing Patient Participation in Clinical Trials: Attract. Engage. Retain. – eCongress eBox Archives Now Available 5Minerva Neurosciences Announces Appointment Of Frederick W. Ahlholm As VP Of Finance And Chief Accounting Officer 2PatientCrossroads Fuels Development of New National Clinical Research Network 2PatientCrossroads Fuels Development of New National Clinical Research Network 3
... Md., Aug. 30 Micromet, Inc.,(Nasdaq: MITI ... of,novel, proprietary antibody-based products for cancer, inflammation and,autoimmune ... and,Chief Executive Officer of Micromet, will present at ... Germany on Wednesday,September 5, 2007 at 9:50am Eastern ...
... Aug. 29 Sucampo,Pharmaceuticals, Inc. (Nasdaq: SCMP ) ... have exercised in full their option to,purchase 562,500 shares ... that the closing of that purchase took place on ... closing were sold by a selling,stockholder and Sucampo did ...
... Mass., Aug. 29 Millennium,Pharmaceuticals, Inc. (Nasdaq: ... presentation,at the Thomas Weisel Partners 2007 Healthcare ... accessed by visiting the Investors section of ... http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO ) The presentation ...
Cached Biology Technology:Micromet, Inc. to Present at the Sal. Oppenheim 2nd European Healthcare Conference 2Sucampo Pharmaceuticals Announces Exercise and Closing of IPO Over-Allotment Option 2Thomas Weisel Partners 2007 Healthcare Conference To Webcast Millennium Presentation 2
(Date:7/14/2014)... the discovery and description of Rhipidocyrtus muiri - ... out to represent a new genus and species. The long ... Borneo is discussed in a recent paper published in the ... holotype male, and only known specimen of Rhipidocyrtus muiri ... to this it was transferred among several researchers in the ...
(Date:7/14/2014)... in the local environment manage much better in the ... environments. , A world without bees would be ... an additional 600 million to 1 billion Danish kroner ... bees making honey and pollinating a wide range of ... bees all over the world are under pressure from ...
(Date:7/14/2014)... Roquin protein, discovered in 2005, controls T-cell activation ... mRNAs. In doing so, it helps to guarantee ... body,s own structures that can lead to autoimmune ... diseases affect between five and ten per cent ... result of complex environmental influences when a genetic ...
Breaking Biology News(10 mins):Serendipity at the Smithsonian: The 107-year journey of the beetle Rhipidocyrtus muiri 2Serendipity at the Smithsonian: The 107-year journey of the beetle Rhipidocyrtus muiri 3Best for bees to be stay-at-homes 2Molecular mechanisms underlying the prevention of autoim-munity by Roquin revealed 2
... Boston University have taught bacteria how to count. Professor ... sequence of genes that allow the microbes to count ... potential applications, which could include drug delivery and sensing ... application still to be addressed within synthetic biology: Can ...
... Each year the American Institute of Biological ... outstanding contributions to the biological sciences. Since ... annually to individuals who have made significant scientific ... fields of integrative and organismal biology. The ...
... Ludwig Institute for Cancer Research at the University of ... remarkable property of the contractile ring, a structure required ... works to divide the cell may facilitate development of ... The researchers show that even though both ...
Cached Biology News:Boston University biomedical engineers teach bacteria to count 2Boston University biomedical engineers teach bacteria to count 3Two Central High (Philadelphia) grads honored by AIBS 2Study may aid efforts to prevent uncontrolled cell division in cancer 2
Protein Kinase D2 Immunogen: Human protein kinase D2. Storage: -20 C, Avoid Freeze/Thaw Cycles...
...
... Upright Freezer Inventory Storage Racks for ... available to fit all makes and ... Made of high quality stainless ... high fiberboard, stainless steel or plastic ...
Many mammalian cell types and experimental situations create challenges for standard transfection experiments. The ViraPower Lentiviral Expression System overcomes these challenges with efficient vir...
Biology Products: